advertisement

blood cancer

machado: why are we so scared of asking for a second opinion?

say what you want about a patient's right to another opinion or how offended a doctor gets to be about said opinion, the bottom line is asking questions and getting more information is good for everyone.
lisa machado
dec 16 2023

opinion: car t-cell therapy delays jeopardize lives of canadians with blood cancer

we call for a multi-stakeholder approach that includes government, regulatory and reimbursement bodies, the pharmaceutical industry, clinician and patient leaders to develop solutions that address both healthcare system challenges and the plight of patients who cannot afford to wait.
sabrina hanna, bsc.
nov 20 2023

machado: medical trauma isn't recognized as ptsd, but it should be

we typically think of traumatic stress as being reserved for those who have survived horrific events like war or violence, but a scary diagnosis, a painful procedure or being ignored when you are in pain can also have mental health consequences.
lisa machado
oct 14 2023

machado: why is it so hard for doctors to acknowledge side effects?

whether it's because of the nocebo effect, difficulty admitting they can't always "do no harm," or poor communication skills, when a healthcare provider doesn't acknowledge the impact of medication, it hurts the patient.
lisa machado
oct 6 2023

lymphoma patients continue to suffer from fear, anxiety and depression

despite gruelling radiotherapy, chemotherapy, a marrow transplant and an allograft, it's the emotional and mental trauma that stands out for guy bouguet decades after his lymphoma diagnosis.
andrew robichaud
sep 15 2023

machado: it's time to dismantle a system that makes survival too expensive

gleevec, the "miracle" drug for chronic myelogenous leukemia, helped kick off the trend of expensive precision medicine. are unaffordable medications leaving patients — and their doctors — to make treatment decisions based on cost?
lisa machado
sep 5 2023

machado: would you stop taking life-saving medication if the side effects made it hard to be alive?

we tend to think stopping treatment that is extending survival is a choice between living or dying, but perhaps it's simply deciding how you want spend your life on your way to death.
lisa machado
aug 8 2023

cmml: treating a difficult rare blood cancer

chronic myelomonocytic leukemia affects about three in a million canadians, and whether treatment is successful or not is often related to age, with younger patients tending to do better, says toronto oncologist dr. jeff lipton.
karen hawthorne
jun 19 2023
powered by
the leukemia & lymphoma society of canada (llsc)
powered by
obesity matters
powered by
canadian society for exercise physiology

machado: why are we so scared of asking for a second opinion?

say what you want about a patient's right to another opinion or how offended a doctor gets to be about said opinion, the bottom line is asking questions and getting more information is good for everyone.
lisa machado
dec 16 2023

opinion: car t-cell therapy delays jeopardize lives of canadians with blood cancer

we call for a multi-stakeholder approach that includes government, regulatory and reimbursement bodies, the pharmaceutical industry, clinician and patient leaders to develop solutions that address both healthcare system challenges and the plight of patients who cannot afford to wait.
sabrina hanna, bsc.
nov 20 2023

machado: medical trauma isn't recognized as ptsd, but it should be

we typically think of traumatic stress as being reserved for those who have survived horrific events like war or violence, but a scary diagnosis, a painful procedure or being ignored when you are in pain can also have mental health consequences.
lisa machado
oct 14 2023

machado: why is it so hard for doctors to acknowledge side effects?

whether it's because of the nocebo effect, difficulty admitting they can't always "do no harm," or poor communication skills, when a healthcare provider doesn't acknowledge the impact of medication, it hurts the patient.
lisa machado
oct 6 2023
powered by
the leukemia & lymphoma society of canada (llsc)

lymphoma patients continue to suffer from fear, anxiety and depression

despite gruelling radiotherapy, chemotherapy, a marrow transplant and an allograft, it's the emotional and mental trauma that stands out for guy bouguet decades after his lymphoma diagnosis.
andrew robichaud
sep 15 2023

machado: it's time to dismantle a system that makes survival too expensive

gleevec, the "miracle" drug for chronic myelogenous leukemia, helped kick off the trend of expensive precision medicine. are unaffordable medications leaving patients — and their doctors — to make treatment decisions based on cost?
lisa machado
sep 5 2023

machado: would you stop taking life-saving medication if the side effects made it hard to be alive?

we tend to think stopping treatment that is extending survival is a choice between living or dying, but perhaps it's simply deciding how you want spend your life on your way to death.
lisa machado
aug 8 2023

cmml: treating a difficult rare blood cancer

chronic myelomonocytic leukemia affects about three in a million canadians, and whether treatment is successful or not is often related to age, with younger patients tending to do better, says toronto oncologist dr. jeff lipton.
karen hawthorne
jun 19 2023
powered by
obesity matters

advertisement

advertisement